HomeTrialNCT07339735
🔬NCT07339735Phase 1ACTIVE NOT RECRUITING

A Study of LY4064809 in Healthy Adult Participants

Study Summary

The purpose of this study is to find out how much LY4064809 gets into the blood stream and how long it takes the body to get rid of it when it is given as two formulations. For each participant, the study will last about nine weeks. Participants will remain in the clinical research center for about one month.

View on ClinicalTrials.gov ↗
Study Details
Enrollment24 participants
Primary Completion
Lead SponsorEli Lilly and Company
Data Retrieved2026-04-11 02:55:33.866870+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.